The influence of intravesical ions, osmolality, pH value, and active transurothelial NaCl-transport inhibition (furosemide) on the rat bladder volume-pressure response was studied according to the concept of a permeable urothelium and according to direct effects of osmolality and K+ on in vitro muscle preparations. It was found that the bladder capacity was decreased by K+, hyperosmolality and pH5, whereas it was increased by hypoosmolality, electrolyte-free media, furosemide and pH 8. The effects were found to be pronounced after dimethyl sulfoxide (DMSO) exposure. In this condition, furosemide showed less effect. It has been suggested that, especially in diseased bladders with increased permeability, frequent voiding and painful urge sensations are due to an enhanced urine access to nerve and muscle cells of the detrusor. On the other hand, frequent voiding reduces the urinary contact time within the bladder, thereby protecting from urine recirculation and thus from renal insufficiency. It has been further suggested that the bladder is not exclusively under central nervous control. As far as the present study is concerned, CO2, water, and normal saline do not seem to be appropriate urodynamic test media for providing the standard situation of bladder filling.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000472470DOI Listing

Publication Analysis

Top Keywords

intravesical ions
8
ions osmolality
8
rat bladder
8
dmso exposure
8
frequent voiding
8
bladder
6
osmolality influence
4
influence volume
4
volume pressure
4
pressure response
4

Similar Publications

In non-muscle invasive bladder cancer, Bacillus Calmette-Guérin (BCG) responders benefit from strong Th1-type inflammatory and T cell responses mediating tumor rejection. However, the corresponding lack of anti-inflammatory Th2-type immunity impairs tissue repair in the bladder wall and facilitates the development of cystitis, causing urinary pain, urgency, incontinence, and frequency. Mechanistically, the leakage of the glycosaminoglycan (GAG) layer enables an influx of potassium ions, bacteria, and urine solutes towards the underlying bladder tissue, promoting chronic inflammation.

View Article and Find Full Text PDF

Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation Thiol-Maleimide Click Reaction for Intravesical Drug Delivery.

ACS Appl Bio Mater

March 2024

Department of Polymer Materials and Engineering, School of Physics and Materials Science, Nanchang University, Nanchang 330031, China.

The development of nanocarriers to prolong the residence time and enhance the permeability of chemotherapeutic drugs on bladder mucosa is important in the postsurgery treatment of superficial bladder cancers (BCs). Here, the mucoadhesive HA-SH/PF127 nanogels composed of a temperature-sensitive Pluronic F127 (PF127) core and thiolated hyaluronic acid (HA-SH) shell were prepared by the emulsification/solvent evaporation method. The nanogels were constructed through the thiol-maleimide click reaction in the HA-SH aqueous side of the oil-water interface and self-oxidized cross-linking thiols between HA-SH.

View Article and Find Full Text PDF

Purpose: Non-muscle-invasive bladder cancer (NMIBC) can recur, partly due to seeding of free tumour cells after transurethral resection of bladder tumour (TURBT). Intravesical chemotherapy post-TURBT can reduce the risk but is used infrequently and inconsistently due to cost, complexity and side effects. The objective of this study was to prospectively assess continuous bladder irrigation using water, which may be a safer and easier alternative with comparable effectiveness.

View Article and Find Full Text PDF

Interstitial cystitis/painful bladder syndrome (IC/PBS) is a chronic disease for which no effective treatment is available. Transforming growth factor-β (TGF-β) is thought to be involved in the pathogenesis of IC/PBS, and previous studies have suggested that administrations of a TGF-β inhibitor significantly ameliorated IC/PBS in a mouse model. However, the molecular mechanisms underlying the therapeutic effect of a TGF-b inhibitor on IC/PBS has not been comprehensively analyzed.

View Article and Find Full Text PDF

Patients with non-muscle invasive bladder cancer (NMIBC) that are unresponsive to Bacillus Calmette-Guérin (BCG) have historically had limited treatment options. A new perspective is represented by OncoTherad® (MRB-CFI-1) immunotherapy, a nanostructured inorganic phosphate complex associated with glycosidic protein, developed by the University of Campinas in Brazil. Previous studies have shown that Platelet-Rich Plasma (PRP) also acts on immune activation and exerts antitumor effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!